subject: UMLS:C3537249

subject_name: D Vitamin


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: Corrosive injury

tested_intervention: unsure


subject: CHEBI:47657

subject_name: Roflumilast

object_name: Chronic obstructive pulmonary disease of horses

tested_intervention: yes


subject: CHEBI:47657

object_name: COPD, severe early onset


subject: KEGG.COMPOUND:C02380

object_name: lymphoid leukemia


subject: CHEBI:2208

subject_name: Mercaptopurine


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:94265

subject_name: Cerubidin


subject: CHEBI:64677

subject_name: Cerubidine


subject: CHEBI:41977

subject_name: Daunorubicin


subject: UNII:7D96IR0PPM

subject_name: Pegaspargase


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:143658


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:41879

subject_name: Dexamethasone


subject: UNII:FTK8U1GZNX

subject_name: THIOGUANINE

object_name: acute lymphoblastic leukemia


subject: UNII:FTK8U1GZNX


subject: CHEBI:9555

subject_name: Tioguanine


subject: CHEBI:8499

subject_name: Propranolol

object_name: dystocia


subject: CHEBI:8499

object_name: Obstructed labor


subject: PR:000014196

subject_name: eukaryotic-type large ribosomal subunit protein uL22

object_name: Unresectable Hepatocellular Carcinoma


subject: PR:000001919

subject_name: programmed cell death protein 1


subject: UMLS:C5392068

subject_name: PD-L1 Inhibitors


subject: UMLS:C4721962

object_name: epilepsy


subject: CHEBI:71013

subject_name: Perampanel


subject: UMLS:C5240314

subject_name: Substance with renin-angiotensin system inhibitor mechanism of action (substance)

object_name: Heart failure with reduced ejection fraction


subject: CHEBI:150712

subject_name: Hyaluronic acid

object_name: temporomandibular joint dysfunction syndrome


subject: CHEMBL.COMPOUND:CHEMBL5314376

subject_name: HYALURONIC ACID


subject: CHEBI:32016

subject_name: Pirfenidone

object_name: Radiation Fibrosis


subject: CHEBI:32016

object_name: radiation pneumonitis


subject: UMLS:C5204560

subject_name: Enadenotucirev-expressing Anti-CD40 Agonistic Monoclonal Antibody NG-350A

object_name: Epithelioma


subject: UMLS:C5204560

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C5204560

object_name: Embolism, Tumor


subject: UMLS:C5204560

object_name: Neoplasm Metastasis


subject: UMLS:C0359156

subject_name: Thymoglobulin

object_name: Severe Aplastic Anemia


subject: UMLS:C0359156

object_name: severe aplastic anemia


subject: GTOPDB:7730

subject_name: bococizumab

object_name: Hypercholesterolemia


subject: CHEMBL.COMPOUND:CHEMBL3137349

subject_name: BOCOCIZUMAB


subject: UMLS:C4043705


subject: UMLS:C5227743


subject: UMLS:C4550206


subject: CHEBI:6801

subject_name: Metformin

object_name: Pick Complex


subject: CHEBI:6801

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: CHEBI:6801

object_name: frontotemporal dementia


subject: CHEBI:6801

object_name: Pick disease


subject: CHEBI:3374

subject_name: Capsaicin

object_name: type 2 diabetes mellitus


subject: CHEBI:3374

object_name: Insulin resistance


subject: CHEBI:3374

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:3374

object_name: obesity


subject: CHEBI:3374

object_name: Obesity, CTCAE


subject: CHEBI:41423

subject_name: Celecoxib

object_name: Prognostic Stage I Breast Cancer AJCC v8


subject: CHEBI:41423

object_name: malignant neoplasm of breast stage I


subject: CHEBI:41423

object_name: Anatomic Stage I Breast Cancer AJCC v8


subject: CHEBI:41423

object_name: Carcinoma breast stage I


subject: CHEBI:41423

object_name: Breast cancer stage II


subject: CHEBI:41423

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: CHEBI:41423

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: CHEBI:41423

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: CHEBI:41423

object_name: Stage IIIC Breast Cancer AJCC v6


subject: CHEBI:41423

object_name: Stage IIIC Breast Cancer AJCC v7


subject: CHEBI:41423

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:41423

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:41423

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:41423

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:41423

object_name: Stage IIIA Breast Carcinoma


subject: CHEBI:41423

object_name: Stage IIIB Breast Carcinoma


subject: CHEBI:41423

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:41423

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: CHEMBL.COMPOUND:CHEMBL4297562

object_name: endometrial cancer


subject: CHEMBL.COMPOUND:CHEMBL4297562

object_name: uterine corpus cancer


subject: CHEMBL.COMPOUND:CHEMBL4297562

object_name: endometrial carcinoma


subject: UMLS:C3274547

subject_name: Sirexatamab


subject: UMLS:C3274547


subject: UMLS:C3274547


subject: CHEBI:291342

subject_name: Desloratadine

object_name: Allergic Rhinitis, CTCAE


subject: CHEBI:94559

subject_name: Levocetirizine

object_name: Atopic rhinitis


subject: CHEBI:94559


subject: MESH:D000077203

subject_name: Sodium-Glucose Transporter 2 Inhibitors

object_name: Heart failure with normal ejection fraction


subject: UMLS:C1384659

object_name: non-small cell lung carcinoma


subject: CHEBI:49960

subject_name: Vandetanib


subject: PUBCHEM.COMPOUND:54675783

subject_name: minocycline

object_name: optic neuritis


subject: PUBCHEM.COMPOUND:54675783

object_name: multiple sclerosis


subject: UMLS:C4305780

object_name: campylobacteriosis


subject: CHEBI:61397

subject_name: Neratinib

object_name: carcinoma


subject: CHEBI:61397

object_name: neoplasm


subject: CHEBI:79699

subject_name: Temsirolimus


subject: CHEBI:79699


subject: CHEBI:5050

subject_name: Fexofenadine

object_name: Hay fever


subject: PUBCHEM.COMPOUND:12443252

subject_name: Tauroursodeoxycholic acid

object_name: amyotrophic lateral sclerosis


subject: CHEBI:80774

subject_name: taurursodiol


subject: CHEBI:85989

subject_name: Avycaz


subject: UMLS:C3656596

subject_name: avibactam / ceftazidime


subject: UMLS:C4086713

subject_name: Substance with programmed cell death protein 1 inhibitor mechanism of action (substance)

object_name: Recurrent disease


subject: UMLS:C4086713

object_name: Global Relapse in Viscera


subject: UMLS:C4086713

object_name: Global Relapse in Lymph Nodes


subject: UMLS:C4086713

object_name: Relapse Following Intervention for Kawasaki Disease


subject: UMLS:C4086713

object_name: Global Relapse


subject: UMLS:C4086713

object_name: Global Relapse in Skin


subject: UMLS:C4086713

object_name: Global Relapse in Blood


subject: UMLS:C4086713

object_name: Refractory Hodgkin Lymphoma


subject: UMLS:C4086713

object_name: Refractory Childhood Hodgkin Lymphoma


subject: UMLS:C4086713

object_name: Adult Hodgkin Lymphoma


subject: CHEBI:74067

subject_name: Ile-Ile

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: CHEBI:74067


subject: PR:000001822

subject_name: MHC class II histocompatibility antigen gamma chain


subject: PR:000001822


subject: PR:000007904


subject: PR:000007904


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: Metastatic Kidney Carcinoma


subject: UNII:M89N0Q7EQR

object_name: nonpapillary renal cell carcinoma


subject: UNII:M89N0Q7EQR

object_name: clear cell renal carcinoma


subject: UNII:M89N0Q7EQR

object_name: Stage III Renal Cell Cancer AJCC v7


subject: UNII:M89N0Q7EQR

object_name: Stage IV Renal Cell Cancer AJCC v7


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: CHEBI:132082

subject_name: Entinostat


subject: CHEBI:132082


subject: CHEBI:132082


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: cancer


subject: CHEBI:192614

object_name: neoplasm


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: UNII:L6WO34R9YG


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: PUBCHEM.COMPOUND:131769997


subject: CHEBI:183660

subject_name: Acetildenafil


subject: CHEBI:183660


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: UNII:80X7B1F6NW


subject: CHEBI:9139

subject_name: Sildenafil


subject: CHEBI:9139


subject: MESH:C488052

subject_name: Physioneal 35

object_name: end stage renal failure


subject: MESH:C488052

object_name: Chronic uremia


subject: MESH:C488051

subject_name: Physioneal 40


subject: MESH:C488051


subject: PUBCHEM.COMPOUND:129264140

subject_name: Brigimadlin

object_name: Advanced Soft Tissue Sarcoma


subject: UNII:9A934ZAN94

subject_name: BRIGIMADLIN


subject: UNII:5V1UI86573

subject_name: EZABENLIMAB


subject: UMLS:C4329334

subject_name: Ezabenlimab


subject: MESH:C089950

subject_name: MF59 oil emulsion

object_name: influenza


subject: CHEBI:83766

subject_name: Olaparib

object_name: endometrial carcinoma


subject: CHEBI:114785

subject_name: Erlotinib

object_name: lung large cell carcinoma


subject: CHEBI:114785

object_name: Non-small cell lung cancer recurrent


subject: CHEBI:114785

object_name: Non-small cell lung cancer stage IIIB


subject: CHEBI:114785

object_name: squamous cell lung carcinoma


subject: CHEBI:114785

object_name: lung adenocarcinoma


subject: CHEBI:4672

subject_name: Docetaxel

object_name: pancreatic adenocarcinoma


subject: CHEBI:4672

object_name: Stage IA Pancreatic Cancer AJCC v8


subject: CHEBI:4672

object_name: Stage IA Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:4672

object_name: stage IB pancreatic cancer


subject: CHEBI:4672

object_name: Stage IB Pancreatic Cancer AJCC v8


subject: CHEBI:4672

object_name: Stage IB Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:4672

object_name: stage IIB pancreatic cancer


subject: CHEBI:4672

object_name: Stage IIB Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:4672

object_name: Stage IIB Pancreatic Cancer AJCC v8


subject: CHEBI:4672

object_name: Stage IIA Pancreatic Cancer AJCC v8


subject: CHEBI:4672

object_name: Stage IIA Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:4672

object_name: stage IIA pancreatic cancer


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: GTOPDB:13085

subject_name: adebrelimab

object_name: colorectal cancer


subject: GTOPDB:13085

object_name: colorectal carcinoma


subject: GTOPDB:13085

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: GTOPDB:13085

object_name: non-small cell lung carcinoma


subject: UNII:1XBY50W1OX

subject_name: ADEBRELIMAB


subject: UNII:1XBY50W1OX


subject: UNII:1XBY50W1OX


subject: UNII:1XBY50W1OX


subject: UMLS:C4725109


subject: UMLS:C4725109


subject: UMLS:C4725109


subject: UMLS:C4725109


subject: CHEBI:31348

subject_name: Capecitabine


subject: UMLS:C5706429

subject_name: KRAS G12C Inhibitor HS-10370


subject: UMLS:C5706429


subject: UMLS:C5706429


subject: UMLS:C5706429


subject: UMLS:C5706368

subject_name: Anti-B7-H3 Antibody-drug Conjugate HS-20093


subject: UMLS:C5706368


subject: UMLS:C5706368


subject: UMLS:C5706368


subject: CHEBI:33364

subject_name: Platinum


subject: CHEBI:33364


subject: CHEBI:33364


subject: CHEMBL.COMPOUND:CHEMBL1235478

subject_name: PLATINUM


subject: CHEMBL.COMPOUND:CHEMBL1235478


subject: CHEMBL.COMPOUND:CHEMBL1235478


subject: UMLS:C1171558

subject_name: Platinum metallicum, platinum, Homeopathic preparation


subject: UMLS:C1171558


subject: UMLS:C1171558


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:31355


subject: UMLS:C2362561

subject_name: Gluten

object_name: Gluten intolerance


subject: UMLS:C2362561

object_name: History of gluten sensitivity


subject: UMLS:C2827346

subject_name: wheat gluten extract


subject: UMLS:C2827346


subject: UMLS:C5418109


subject: UMLS:C5418108


subject: CHEBI:10588

subject_name: m-Chlorophenylpiperazine

object_name: cocaine abuse


subject: GTOPDB:6749

subject_name: fibrinogen

object_name: Hemorrhage


subject: GTOPDB:6749

object_name: Physical trauma


subject: GTOPDB:6749

object_name: Injury


subject: GTOPDB:6749

object_name: Trauma


subject: KEGG.COMPOUND:C00393

subject_name: Fibrinogen


subject: KEGG.COMPOUND:C00393


subject: KEGG.COMPOUND:C00393


subject: KEGG.COMPOUND:C00393


subject: UMLS:C3540039

subject_name: Fibrinogen containing hemostatics


subject: UMLS:C3540039


subject: UMLS:C3540039


subject: UMLS:C3540039


subject: UMLS:C2587184

subject_name: Parenogen


subject: UMLS:C2587184


subject: UMLS:C2587184


subject: UMLS:C2587184


subject: UMLS:C0016006


subject: UMLS:C0016006


subject: UMLS:C0016006


subject: UMLS:C0016006


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: plasma cell myeloma


subject: CHEBI:2038

subject_name: Azacitidine


subject: GTOPDB:12989

subject_name: toripalimab

object_name: Rash and Dermatitis Associated with Radiation Excluding Chemoradiation, CTCAE


subject: GTOPDB:12989

object_name: radiation exposure measurement


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: UMLS:C4329337


subject: UNII:3Z11398FNQ


subject: UMLS:C5435291


subject: UMLS:C4733679

subject_name: ADC BA3011

object_name: ovarian cancer


subject: UMLS:C4733679

object_name: ovarian neoplasm


subject: UMLS:C4733679

object_name: ovarian carcinoma


subject: UMLS:C4733657

subject_name: ADC BA3021


subject: UMLS:C4733657


subject: UMLS:C4733657


subject: DRUGBANK:DB17340


subject: DRUGBANK:DB17340


subject: DRUGBANK:DB17340


subject: GTOPDB:12989


subject: GTOPDB:12989


subject: GTOPDB:12989


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UMLS:C4329337


subject: UMLS:C4329337


subject: UMLS:C4329337


subject: UMLS:C5667119

object_name: severe COVID-19


subject: CHEBI:145994

subject_name: Remdesivir


subject: UMLS:C1511563

subject_name: Curcumin C3 Complex

object_name: Alzheimer disease


subject: UMLS:C2825026

subject_name: Unfractionated Heparin [EPC]


subject: CHEBI:84040

object_name: coronary microvascular disorder


subject: CHEBI:36002

subject_name: cis-resveratrol


subject: UMLS:C1101322

subject_name: trans-Resveratrol


subject: CHEBI:27881

subject_name: resveratrol


subject: CHEBI:93775

subject_name: Amethopterin

object_name: atopic eczema


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:93775

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:50681


subject: CHEBI:44185


subject: CHEBI:66919

subject_name: Ruxolitinib

object_name: Myelodysplasia


subject: CHEBI:66919

object_name: Adult Myelodysplastic Syndrome


subject: CHEBI:66919

object_name: childhood myelodysplastic syndrome


subject: CHEBI:66919

object_name: Myelodysplastic Syndrome, CTCAE


subject: CHEBI:94265

subject_name: Cerubidin

object_name: precursor B-cell acute lymphoblastic leukemia


subject: CHEBI:94265

object_name: B-cell acute lymphoblastic leukemia


subject: CHEBI:64677

subject_name: Cerubidine


subject: CHEBI:64677


subject: CHEBI:41977

subject_name: Daunorubicin


subject: CHEBI:41977


subject: UNII:7D96IR0PPM

subject_name: Pegaspargase


subject: UNII:7D96IR0PPM


subject: CHEBI:143658


subject: CHEBI:38545

subject_name: Rosuvastatin

object_name: Carotid Artery Plaque


subject: CHEBI:38545

object_name: ankylosing spondylitis


subject: CHEBI:38545

object_name: rheumatoid arthritis


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE

object_name: Helicobacter pylori infection


subject: CHEBI:6909

subject_name: Metronidazole


subject: CHEBI:63627

subject_name: Tinidazole


subject: UMLS:C4764260

subject_name: PI3K-delta Inhibitor YY-20394

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:64073

object_name: hypopituitarism


subject: CHEBI:64073

object_name: Hypopituitarism, CTCAE


subject: CHEBI:64073

object_name: Oxytocin deficiency


subject: CHEBI:64073

object_name: pituitary hormone deficiency, combined, 2


subject: CHEBI:64073

object_name: panhypopituitarism


subject: CHEBI:64073

object_name: hypothalamic disorder


subject: CHEBI:64073

object_name: mental disorder


subject: CHEBI:64073

object_name: pituitary gland disorder


subject: CHEBI:64073

object_name: Diminishment of relationship seeking


subject: CHEBI:64073

object_name: central diabetes insipidus


subject: CHEBI:64073

object_name: neurohypophyseal diabetes insipidus


subject: UNII:9P1872D4OL

subject_name: Exenatide


subject: UNII:9P1872D4OL


subject: UNII:9P1872D4OL


subject: UNII:9P1872D4OL


subject: UNII:9P1872D4OL


subject: UNII:9P1872D4OL


subject: UNII:9P1872D4OL


subject: UNII:9P1872D4OL


subject: UNII:9P1872D4OL


subject: UNII:9P1872D4OL


subject: UNII:9P1872D4OL


subject: UMLS:C5555596

subject_name: Epstein-Barr Virus gp350-ferritin Nanoparticle Vaccine with Saponin-based Adjuvant

object_name: infectious mononucleosis


subject: UMLS:C5555596

object_name: EBV Infection


subject: DRUGBANK:DB16369

subject_name: Matrix-M


subject: DRUGBANK:DB16369


subject: CHEMBL.COMPOUND:CHEMBL4650407

subject_name: MATRIX-M1 ADJUVANT


subject: CHEMBL.COMPOUND:CHEMBL4650407


subject: UNII:N5UK68MGDZ

subject_name: Apremilast

object_name: atopic eczema


subject: CHEBI:9241

subject_name: Spironolactone

object_name: Arterial Stiffness


subject: CHEBI:135515

subject_name: Bendamustine

object_name: relapsed/refractory diffuse large B-cell lymphoma


subject: CHEBI:135515

object_name: Follicular lymphoma refractory


subject: CHEBI:135515

object_name: Mantle cell lymphoma refractory


subject: CHEBI:135515

object_name: B-cell small lymphocytic lymphoma refractory


subject: CHEBI:135515

object_name: Marginal zone lymphoma refractory


subject: CHEBI:135515

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEBI:135515

object_name: Refractory Transformed Chronic Lymphocytic Leukemia


subject: CHEBI:135515

object_name: Follicular lymphoma recurrent


subject: CHEBI:135515

object_name: Mantle cell lymphoma recurrent


subject: CHEBI:135515

object_name: B-cell non-Hodgkin lymphoma


subject: CHEBI:135515

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:135515

object_name: Marginal zone lymphoma recurrent


subject: CHEBI:135515

object_name: Recurrent Transformed Chronic Lymphocytic Leukemia


subject: CHEBI:135515

object_name: Recurrent Chronic Lymphoid Leukemia


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:31355

subject_name: Carboplatin

object_name: cancer of unknown primary site


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:176724

subject_name: Etiracetam

object_name: Seizure Related to COVID-19


subject: CHEBI:176724

object_name: visual epilepsy


subject: UNII:73HC18Y1LW

subject_name: LEVITIRACETAM


subject: UNII:73HC18Y1LW


subject: CHEBI:6437

subject_name: Levetiracetam


subject: CHEBI:6437


subject: PUBCHEM.COMPOUND:24984318

subject_name: Valbenazine

object_name: Torticollis


subject: UMLS:C5774067

subject_name: ACAM2000 smallpox vaccine

object_name: smallpox


subject: CHEBI:6801

subject_name: Metformin

object_name: inherited lipid metabolism disorder


subject: CHEBI:6801

object_name: Dyslipidemia


subject: UMLS:C2608294

subject_name: Nasal Spray brand of phenylephrine

object_name: Breakthrough cancer pain


subject: UNII:5YV419FIJS

subject_name: sodium glycididazole

object_name: Childhood Breast Carcinoma


subject: UNII:5YV419FIJS

object_name: breast carcinoma


subject: UNII:5YV419FIJS

object_name: breast cancer


subject: CHEBI:74814

subject_name: Ser-Gly


subject: CHEBI:74814


subject: CHEBI:74814


subject: CHEBI:33351

subject_name: seaborgium atom


subject: CHEBI:33351


subject: CHEBI:33351


subject: UNII:3H8GSZ4SQL

subject_name: Avatrombopag

object_name: inherited bleeding disorder, platelet-type


subject: UNII:3H8GSZ4SQL

object_name: blood platelet disease


subject: CHEBI:191043

object_name: osteoarthritis


subject: CHEBI:145499

subject_name: Donepezil

object_name: stroke disorder


subject: CHEBI:145499

object_name: cerebrovascular disorder


subject: CHEBI:42944

subject_name: Galantamine


subject: CHEBI:42944


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: Sleep disorders in children


subject: CHEBI:16796

subject_name: Melatonin


subject: UNII:55KHL3P693

subject_name: Galcanezumab

object_name: Episodic Cluster Headache


subject: UNII:55KHL3P693

object_name: cluster headache syndrome


subject: UNII:04NQ160FRU

subject_name: Strontium ranelate

object_name: Osteopenia


subject: UNII:04NQ160FRU

object_name: primary hyperparathyroidism


subject: UNII:04NQ160FRU

object_name: osteoporosis


subject: UNII:04NQ160FRU

object_name: Encounter due to family history of osteoporosis


subject: UNII:04NQ160FRU

object_name: Osteoporosis, CTCAE 5.0


subject: UNII:04NQ160FRU

object_name: Osteoporosis, CTCAE 3.0


subject: CHEBI:29108

subject_name: Calcium cation


subject: CHEBI:22984

subject_name: Calcium


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: CHEBI:9434

subject_name: Telmisartan

object_name: intracerebral hemorrhage


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: benign prostatic hyperplasia


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: Halitosis


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: CHEBI:52357

subject_name: chlorine dioxide


subject: CHEBI:29415

subject_name: Chlorine oxide


subject: UMLS:C2744646

object_name: ovarian cancer


subject: UMLS:C2744646

object_name: ovarian neoplasm


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: yellow skin or eyes (symptom)


subject: CHEBI:41879

object_name: jaundice


subject: CHEBI:41879

object_name: hyperbilirubinemia


subject: CHEBI:41879

object_name: Decreased liver function


subject: CHEBI:3423

subject_name: Carmustine

object_name: Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified


subject: CHEBI:3423

object_name: Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified


subject: CHEBI:3423

object_name: Recurrent Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma


subject: CHEBI:3423

object_name: Refractory Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma


subject: CHEBI:3423

object_name: Primary mediastinal large B-cell lymphoma refractory


subject: CHEBI:3423

object_name: Primary mediastinal large B-cell lymphoma recurrent


subject: CHEBI:3423

object_name: Refractory High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements


subject: CHEBI:3423

object_name: Recurrent High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: UNII:7K5O7P6QIU

subject_name: LONCASTUXIMAB


subject: UNII:7K5O7P6QIU


subject: UNII:7K5O7P6QIU


subject: UNII:7K5O7P6QIU


subject: UNII:7K5O7P6QIU


subject: UNII:7K5O7P6QIU


subject: UNII:7K5O7P6QIU


subject: UNII:7K5O7P6QIU


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:66899

subject_name: Tafluprost

object_name: OPTN-related open angle glaucoma


subject: CHEBI:66899

object_name: open-angle glaucoma


subject: CHEBI:66899

object_name: Ocular surface disease


subject: CHEBI:66899

object_name: Ocular Surface Disease, CTCAE


subject: CHEBI:39465

subject_name: timolol


subject: CHEBI:39465


subject: CHEBI:39465


subject: RXCUI:901639

subject_name: Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 19A capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 3 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 5 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 6A capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 7F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine Prefilled Syringe

object_name: influenza


subject: UMLS:C3827032

subject_name: Catequentinib Hydrochloride

object_name: nasopharyngeal carcinoma


subject: UMLS:C3827032

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: PUBCHEM.COMPOUND:21937662

subject_name: Isavuconazole

object_name: Zygomycosis


subject: PUBCHEM.COMPOUND:21937662

object_name: invasive aspergillosis


subject: CHEBI:190738

subject_name: Demethylated antipyrine

object_name: amyotrophic lateral sclerosis


subject: CHEBI:190738

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: UNII:S798V6YJRP

subject_name: EDARAVONE


subject: UNII:S798V6YJRP


subject: CHEBI:31530

subject_name: Edaravone


subject: CHEBI:31530


subject: UMLS:C5678710

subject_name: Radicava ORS


subject: UMLS:C5678710


subject: CHEBI:146178

subject_name: RACEMETHORPHAN

object_name: treatment resistant depression


subject: CHEBI:146178


subject: CHEBI:146178

object_name: endogenous depression


subject: CHEBI:146178

object_name: major depressive disorder


subject: CHEBI:146178

object_name: mal de Debarquement


subject: CHEBI:146178

object_name: Minimal Disseminated Disease


subject: CHEBI:146176

subject_name: levomethorphan


subject: CHEBI:146176


subject: CHEBI:146176


subject: CHEBI:146176


subject: CHEBI:146176


subject: CHEBI:146176


subject: CHEBI:4470

subject_name: Dextromethorphan


subject: CHEBI:4470


subject: CHEBI:4470


subject: CHEBI:4470


subject: CHEBI:4470


subject: CHEBI:4470


subject: PUBCHEM.COMPOUND:76641559

subject_name: Dorzagliatin

object_name: Drug Interactions


subject: PUBCHEM.COMPOUND:76641559

object_name: Adverse drug interaction


subject: CHEBI:75998

subject_name: Trametinib

object_name: histiocytosis


subject: CHEBI:75998

object_name: Histiocytic syndrome


subject: PUBCHEM.COMPOUND:154699459

subject_name: taletrectinib

object_name: non-small cell lung carcinoma


subject: UNII:3FTR44B32Q

object_name: dentin sensitivity


subject: CHEBI:135933

subject_name: Tin Fluorides


subject: CHEBI:50853

subject_name: quantum dot

object_name: Dyslipidemia


subject: CHEBI:50749

subject_name: Calcipotriol

object_name: psoriasis vulgaris


subject: UNII:DRP53ZDY6H

object_name: head and neck squamous cell carcinoma


subject: CHEBI:8069

subject_name: Phenobarbital

object_name: epilepsy


subject: CHEBI:63451

subject_name: Infigratinib


subject: CHEBI:63451

object_name: Stomach cancer


subject: CHEBI:63451

object_name: gastric cancer


subject: UMLS:C2830125

object_name: metastatic colorectal cancer


subject: CHEBI:145371

subject_name: Binimetinib


subject: MESH:C000634404

object_name: schizophrenia


subject: UMLS:C0085297

subject_name: immunoglobulins, intravenous

object_name: immunodeficiency disease


subject: UMLS:C0086333

subject_name: Gammagard


subject: UMLS:C0086333

object_name: inborn error of immunity


subject: UNII:U59UGK3IPC

subject_name: Ublituximab

object_name: multiple sclerosis


subject: UMLS:C2934225


subject: CHEBI:9168

subject_name: Sirolimus

object_name: inclusion body myositis


subject: PUBCHEM.COMPOUND:12443252

subject_name: Tauroursodeoxycholic acid

object_name: hypertension


subject: PUBCHEM.COMPOUND:12443252

object_name: Hypertension, CTCAE


subject: CHEBI:80774

subject_name: taurursodiol


subject: CHEBI:80774


subject: CHEBI:83766

subject_name: Olaparib


subject: CHEBI:83766


subject: UNII:XRO4566Q4R

subject_name: INTERFERON BETA

object_name: Macular Edema


subject: UNII:XRO4566Q4R

object_name: intermediate uveitis


subject: CHEBI:183415

object_name: Cognitive impairment


subject: CHEBI:183415

object_name: Attention impaired


subject: CHEBI:183415

object_name: Psychomotor Retardation


subject: CHEBI:66964

subject_name: Dronabinol


subject: CHEBI:66964


subject: CHEBI:66964


subject: CHEBI:145588

object_name: osteoarthritis, knee


subject: PUBCHEM.COMPOUND:168359761

subject_name: Chondroitin sulfate


subject: CHEBI:145591


subject: UNII:NF3P9Z8J5Y

subject_name: baxdrostat

object_name: hyperaldosteronism


subject: UNII:NF3P9Z8J5Y

object_name: Conn's syndrome


subject: DRUGBANK:DB19090

subject_name: Baxdrostat


subject: DRUGBANK:DB19090


subject: CHEBI:132922


subject: CHEBI:132922


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:43415


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:5855


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: Alzheimer disease type 1


subject: CHEBI:89324

object_name: Alzheimer disease


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UMLS:C3714503


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UNII:9VU1KI44GP


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C2936842


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C3537249


subject: UMLS:C1268855

subject_name: Gonadotropin releasing hormone antagonist

object_name: Endometrial Intraepithelial Neoplasia


subject: UMLS:C1268855

object_name: atypical endometrial hyperplasia


subject: UMLS:C1268855

object_name: progesterone resistance


subject: UMLS:C1268855

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C1268855

object_name: obesity


subject: UMLS:C1268855

object_name: Obesity, CTCAE


subject: UMLS:C3537040

subject_name: Gonadotropin Releasing Hormone Antagonist [EPC]


subject: UMLS:C3537040


subject: UMLS:C3537040


subject: UMLS:C3537040


subject: UMLS:C3537040


subject: UMLS:C3537040


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Recurrent disease


subject: CHEBI:4026

object_name: Global Relapse in Viscera


subject: CHEBI:4026

object_name: Global Relapse in Lymph Nodes


subject: CHEBI:4026

object_name: Relapse Following Intervention for Kawasaki Disease


subject: CHEBI:4026

object_name: Global Relapse


subject: CHEBI:4026

object_name: Global Relapse in Skin


subject: CHEBI:4026

object_name: Global Relapse in Blood


subject: CHEBI:4026

object_name: refractory malignant neoplasm


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: MESH:C529609

subject_name: tenoten

object_name: anxiety


subject: MESH:C529609

object_name: anxiety disorder


subject: MESH:C529609

object_name: Anxiety symptoms


subject: MESH:C529609

object_name: Anxiety, CTCAE 3.0


subject: MESH:C529609

object_name: Anxiety, CTCAE 5.0


subject: CHEBI:134703

subject_name: Fluciclovine (18F)

object_name: endometrial cancer


subject: CHEBI:134703

object_name: uterine corpus cancer


subject: CHEBI:134703

object_name: endometrial carcinoma


subject: CHEBI:134703

object_name: ovarian carcinoma


subject: CHEBI:134703

object_name: malignant epithelial tumor of ovary


subject: CHEBI:134703

object_name: cervical cancer


subject: CHEBI:134703

object_name: cervical carcinoma


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: Metastatic angiosarcoma


subject: UMLS:C3896806


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:22652

subject_name: Ascorbic acid

object_name: systemic inflammatory response syndrome


subject: CHEBI:22652

object_name: multiple organ dysfunction syndrome


subject: CHEBI:22652

object_name: Physical trauma


subject: CHEBI:22652

object_name: Trauma


subject: CHEBI:82715

object_name: postherpetic neuralgia


subject: CHEBI:3311

subject_name: Calcium carbonate

object_name: chronic hepatitis B virus infection


subject: CHEBI:27300


subject: UNII:7DP3NTV15T

subject_name: BLEOMYCIN SULFATE

object_name: cardiotoxicity


subject: CHEBI:50223

subject_name: Dexrazoxane


subject: CHEBI:50223

object_name: adult lymphoma


subject: CHEBI:50223

object_name: lymphoma


subject: CHEBI:50223

object_name: pediatric lymphoma


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:4911

subject_name: Etoposide


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: UNII:T5IRO3534A

subject_name: Oncovin


subject: PUBCHEM.COMPOUND:3717450

subject_name: Leurocristine


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:3139

subject_name: bleomycin


subject: UMLS:C4521177

object_name: neurodegenerative disease


subject: CHEBI:6801

subject_name: Metformin


subject: UNII:U2H19X4WBV

subject_name: Tomivosertib

object_name: Solid Neoplasm


subject: UMLS:C4086557


subject: UMLS:C5963447

subject_name: CDC7 Inhibitor

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C5963447

object_name: Embolism, Tumor


subject: UMLS:C5963447

object_name: Neoplasm Metastasis


subject: PUBCHEM.COMPOUND:77256380

subject_name: Glasdegib

object_name: acute myeloid leukemia by FAB classification


subject: PUBCHEM.COMPOUND:77256380

object_name: acute myeloid leukemia


subject: CHEBI:59540

subject_name: (S)-Rolipram

object_name: Depressed mood


subject: CHEBI:59540

object_name: Cancer patients and suicide and depression


subject: CHEBI:59540

object_name: Depressed - symptom


subject: CHEBI:59540

object_name: Depression, CTCAE


subject: UMLS:C5814503

object_name: glycogen storage disease II


subject: CHEBI:50381

subject_name: Miglustat


subject: CHEBI:41948

subject_name: Eflornithine

object_name: Hirsutism


subject: CHEBI:8382

subject_name: Prednisone

object_name: multiple sclerosis


subject: CHEBI:52172

subject_name: Nilotinib

object_name: Lewy Bodies


subject: CHEBI:52172

object_name: Parkinson disease


subject: CHEBI:52172

object_name: Dementia associated with Parkinson's Disease


subject: CHEBI:6456

subject_name: Lidocaine

object_name: anterior cutaneous nerve entrapment syndrome


subject: CHEBI:9667

subject_name: Triamcinolone


subject: PR:000008675

subject_name: heterogeneous nuclear ribonucleoprotein U-like protein 2

object_name: Heart failure with normal ejection fraction


subject: PR:000008675

object_name: chronic kidney disease


subject: PUBCHEM.COMPOUND:54214995

subject_name: Sacubitril


subject: PUBCHEM.COMPOUND:54214995


subject: CHEBI:9927

subject_name: Valsartan


subject: CHEBI:9927


subject: MESH:D000082082

subject_name: Immune Checkpoint Inhibitors

object_name: non-small cell lung carcinoma


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: ankylosing spondylitis


subject: GTOPDB:8002

subject_name: bavituximab

object_name: hepatitis C


subject: UNII:Q16CT95N25


subject: UMLS:C1707382


subject: UMLS:C0597418

subject_name: Rotavirus Vaccines

object_name: Viral gastroenteritis due to Rotavirus


subject: UMLS:C5397359

subject_name: Vaccine product containing only Rotavirus antigen (medicinal product)


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: central nervous system cancer


subject: UNII:2S9ZZM9Q9V

object_name: brain cancer


subject: UNII:A2VM2V569A


subject: UNII:A2VM2V569A


subject: UNII:A2VM2V569A

object_name: brain neoplasm


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: obstructive sleep apnea syndrome


subject: UMLS:C5433403

subject_name: Forxiga


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: UMLS:C3265062


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: PUBCHEM.COMPOUND:6918224

subject_name: QUETIAPINE FUMARATE

object_name: Mania, CTCAE


subject: PUBCHEM.COMPOUND:6918224

object_name: Mania


subject: PUBCHEM.COMPOUND:6918224

object_name: bipolar disorder


subject: PUBCHEM.COMPOUND:6918224

object_name: major affective disorder 1


subject: PUBCHEM.COMPOUND:6918224

object_name: Manic Disorder


subject: CHEBI:8707

subject_name: Quetiapine


subject: CHEBI:8707


subject: CHEBI:8707


subject: CHEBI:8707


subject: CHEBI:33324

subject_name: strontium atom


subject: CHEBI:33324


subject: CHEBI:33324


subject: CHEBI:33324


subject: CHEBI:33324


subject: UNII:55G92WGH3X

subject_name: Telacebec

object_name: Buruli Ulcer


subject: CHEBI:60789

subject_name: bupivacaine hydrochloride hydrate

object_name: endogenous depression


subject: CHEBI:60789

object_name: major depressive disorder


subject: CHEBI:60789

object_name: treatment resistant depression


subject: CHEBI:60789


subject: CHEBI:3215

subject_name: Bupivacaine


subject: CHEBI:3215


subject: CHEBI:3215


subject: CHEBI:3215


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Clear-cell metastatic renal cell carcinoma


subject: CHEBI:30021

subject_name: Selenomethionine

object_name: nonpapillary renal cell carcinoma


subject: CHEBI:30021

object_name: clear cell renal carcinoma


subject: CHEBI:30021


subject: CHEBI:9168

subject_name: Sirolimus


subject: CHEBI:9168


subject: CHEBI:9168


subject: CHEBI:31772

object_name: chronic post-procedural pain


subject: CHEBI:31772

object_name: acute post-thoracotomy pain


subject: CHEBI:31772

object_name: neoplasm of thorax


subject: CHEBI:6149

subject_name: Levobupivacaine


subject: CHEBI:6149


subject: CHEBI:6149


subject: GTOPDB:2479

subject_name: HCl


subject: GTOPDB:2479


subject: GTOPDB:2479


subject: UMLS:C1512523

subject_name: hydrochloride


subject: UMLS:C1512523


subject: UMLS:C1512523


subject: UMLS:C0443985

subject_name: Flinders medical centre-7 marker


subject: UMLS:C0443985


subject: UMLS:C0443985


subject: CHEBI:17883

subject_name: Hydrochloric acid


subject: CHEBI:17883


subject: CHEBI:17883


subject: PUBCHEM.COMPOUND:92131181

object_name: Alzheimer disease type 1


subject: PUBCHEM.COMPOUND:92131181

object_name: Alzheimer disease


subject: UNII:QG24C04E17


subject: UNII:QG24C04E17


subject: UMLS:C5708954


subject: UMLS:C5708954


subject: MESH:C578474

object_name: Acute rhinosinusitis


subject: UNII:AG9MHG098Z

subject_name: Zanubrutinib

object_name: follicular lymphoma


subject: UNII:AG9MHG098Z

object_name: Treatment naive


subject: CHEBI:135515

subject_name: Bendamustine


subject: CHEBI:49603

subject_name: Lapatinib

object_name: Metastatic human epidermal growth factor 2 positive carcinoma of breast


subject: CHEBI:66964

subject_name: Dronabinol

object_name: Drug Interactions


subject: PUBCHEM.COMPOUND:135449332

subject_name: Eltrombopag

object_name: autoimmune thrombocytopenic purpura


subject: CHEBI:33363

subject_name: palladium

object_name: colorectal cancer


subject: CHEBI:33363

object_name: colorectal carcinoma


subject: CHEBI:33363

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:74756

subject_name: Pro-Asp


subject: CHEBI:74756


subject: CHEBI:74756


subject: CHEBI:74868

subject_name: Trp-Asp


subject: CHEBI:74868


subject: CHEBI:74868


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: primary interstitial lung disease specific to childhood


subject: CHEBI:46195

object_name: interstitial lung disease specific to childhood


subject: CHEBI:46195

object_name: Recovery of Function


subject: CHEBI:197437

subject_name: Mocetinostat

object_name: Hodgkin Disease


subject: CHEBI:197437

object_name: Adult Hodgkin Lymphoma


subject: CHEBI:197437

object_name: Childhood Hodgkin Lymphoma


subject: UMLS:C4048878

subject_name: MGCD 0103


subject: UMLS:C4048878


subject: UMLS:C4048878


subject: RXCUI:1942744

subject_name: Vyxeos

object_name: adult acute myeloid leukemia


subject: RXCUI:1942744

object_name: acute myeloid leukemia


subject: DRUGBANK:DB18502

object_name: Niemann-Pick disease, type C1


subject: UMLS:C4528574

subject_name: PTPN11 inhibitor TNO155

object_name: kidney failure


subject: CHEBI:63451

subject_name: Infigratinib

object_name: achondroplasia


subject: PUBCHEM.COMPOUND:135423438

subject_name: Nintedanib

object_name: non-small cell lung carcinoma


subject: CHEBI:85164


subject: CHEBI:135702

subject_name: Belotecan

object_name: ovarian carcinoma


subject: CHEBI:135702

object_name: malignant epithelial tumor of ovary


subject: CHEBI:63632

subject_name: Topotecan


subject: UMLS:C5706431

subject_name: TERN 701

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: UMLS:C5706431

object_name: Leukemia, Myeloid, Chronic-Phase


subject: CHEBI:15372

object_name: intermittent vascular claudication


subject: PUBCHEM.COMPOUND:129630809

subject_name: trihydroxybutyrophenone


subject: CHEBI:173969


subject: CHEBI:59560

subject_name: Sapropterin


subject: CHEBI:6427

subject_name: Leuprolide

object_name: Hot Flashes, CTCAE


subject: CHEBI:6427

object_name: Hot flashes


subject: CHEBI:36080

subject_name: protein

object_name: rheumatoid arthritis


subject: UMLS:C0033684

subject_name: Proteins


subject: PR:000000001


subject: CHEBI:5558

subject_name: Guanfacine

object_name: stroke disorder


subject: CHEBI:5558

object_name: cerebrovascular disorder


subject: CHEBI:5558

object_name: Stroke (heart beat)


subject: CHEBI:5558

object_name: Stroke, CTCAE


subject: CHEBI:5558

object_name: Hemispatial Neglect


subject: CHEBI:50634

object_name: age-related macular degeneration


subject: CHEBI:50634

object_name: diabetic retinopathy


subject: CHEBI:27690

subject_name: Acetazolamide


subject: CHEBI:27690


subject: CHEBI:44423

subject_name: Hydroxyurea

object_name: Adult Gliosarcoma


subject: CHEBI:44423

object_name: gliosarcoma


subject: CHEBI:44423

object_name: Childhood Gliosarcoma


subject: CHEBI:45783

subject_name: Imatinib

object_name: glioblastoma


subject: CHEBI:45783

object_name: Childhood Glioblastoma


subject: CHEBI:45783

object_name: adult glioblastoma


subject: CHEBI:45783


subject: CHEBI:45783


subject: CHEBI:45783


subject: UMLS:C2733644

subject_name: Black Seed Oil

object_name: hypertension


subject: UMLS:C2733644

object_name: Hypertension, CTCAE


subject: CHEBI:94366

subject_name: itraconazole

object_name: histoplasmosis


subject: CHEBI:94366

object_name: HIV infection


subject: PUBCHEM.COMPOUND:135565596

subject_name: Copanlisib

object_name: endometrial cancer


subject: PUBCHEM.COMPOUND:135565596

object_name: uterine corpus cancer


subject: PUBCHEM.COMPOUND:135565596

object_name: endometrial carcinoma


subject: PUBCHEM.COMPOUND:135565596

object_name: follicular lymphoma


subject: CHEBI:173077


subject: CHEBI:173077


subject: CHEBI:173077


subject: CHEBI:173077


subject: CHEBI:2955

subject_name: Azithromycin

object_name: kwashiorkor


subject: CHEBI:2955

object_name: campylobacteriosis


subject: CHEBI:2955

object_name: hereditary endocrine growth disease


subject: UMLS:C1508746

subject_name: egg extract


subject: DRUGBANK:DB10529

subject_name: Egg


subject: UMLS:C0770246

subject_name: PROTEIN SUPPLEMENTS


subject: UMLS:C0770246


subject: UMLS:C0770246


subject: UMLS:C5555566

subject_name: Anti-PD-L1 Monoclonal Antibody LP002

object_name: Primary mediastinal large B-cell lymphoma (PMBCL)


subject: UMLS:C2983764

object_name: Hepatic impairment


subject: CHEBI:231693

subject_name: Capmatinib


subject: CHEBI:45783

object_name: malignant mesothelioma


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: osteoarthritis, hip


subject: CHEBI:46195

object_name: Arthralgia


subject: CHEBI:46195

object_name: Joint Pain, CTCAE


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: CHEBI:41423

subject_name: Celecoxib


subject: CHEBI:41423


subject: CHEBI:41423


subject: UMLS:C4740825

subject_name: Oxervate

object_name: dry eye syndrome


subject: UMLS:C4740825

object_name: Dry Eye, CTCAE


subject: UMLS:C4740825

object_name: Dryness of eye


subject: UMLS:C5554928

subject_name: HER2 Inhibitor ZN-A-1041

object_name: HER2 positive breast carcinoma


subject: PUBCHEM.COMPOUND:16138701

subject_name: DiaPep 277

object_name: type 1 diabetes mellitus


subject: UNII:F8778UWB0A


subject: DRUGBANK:DB18608

subject_name: Sapablursen

object_name: thalassemia


subject: UMLS:C5666871

subject_name: Ionis tmprss6-lrx


subject: UMLS:C5691165

subject_name: Auxora

object_name: pneumonia


subject: UMLS:C5691165

object_name: COVID-19-Associated Pneumonia


subject: CHEBI:72690

subject_name: Pomalidomide

object_name: medulloblastoma


subject: CHEBI:72690

object_name: childhood medulloblastoma


subject: CHEBI:72690

object_name: adult medulloblastoma


subject: CHEBI:72690

object_name: central nervous system cancer


subject: UNII:6A1X56B95E

subject_name: Rapastinel

object_name: major depressive disorder


subject: UMLS:C1666271

subject_name: GLYX-13 peptide


subject: UMLS:C1446647

subject_name: Milk antigen

object_name: Constipation


subject: UMLS:C1446647

object_name: Constipation, CTCAE


subject: DRUGBANK:DB10543

subject_name: Cow milk


subject: DRUGBANK:DB10543


subject: UMLS:C0444318

subject_name: Milk Specimen


subject: UMLS:C0444318


subject: CHEBI:2668

subject_name: Amlodipine

object_name: Iron Overload


subject: CHEBI:2668

object_name: iron poisoning


subject: CHEBI:2668

object_name: Iron Overload, CTCAE


subject: CHEBI:2668

object_name: beta thalassemia


subject: CHEBI:2668

object_name: beta-thalassemia HBB/LCRB


subject: UMLS:C5690388

object_name: post-traumatic stress disorder


subject: CHEBI:58097

object_name: chronic obstructive pulmonary disease


subject: CHEBI:58097

object_name: interstitial lung disease


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:35854

subject_name: Valaciclovir

object_name: herpes simplex


subject: CHEBI:35854

object_name: chickenpox


subject: CHEBI:31527

subject_name: Dydrogesterone

object_name: pregnancy disorder


subject: CHEBI:23965

subject_name: estradiol


subject: UNII:961YV2O515

subject_name: Efgartigimod alfa

object_name: optic neuritis


subject: DRUGBANK:DB17293

subject_name: Hiltonol

object_name: malignant glioma


subject: UNII:7KYP9TKT70

subject_name: poly ICLC


subject: CHEBI:76128

subject_name: Dexketoprofen

object_name: Musculoskeletal Pain


subject: CHEBI:46195

subject_name: Acetaminophen


subject: MESH:C097921

object_name: prostate carcinoma


subject: MESH:C097921

object_name: prostate cancer


subject: MESH:C097921

object_name: Embolism, Tumor


subject: MESH:C097921

object_name: Neoplasm Metastasis


subject: MESH:C097921

object_name: Metastasis


subject: MESH:C097921

object_name: Metastatic Lesion


subject: CHEBI:50819

subject_name: Ferric oxide


subject: CHEBI:50819


subject: CHEBI:50819


subject: CHEBI:50819


subject: CHEBI:50819


subject: CHEBI:50819


subject: PUBCHEM.COMPOUND:9934746

subject_name: ensifentrine

object_name: Chronic obstructive pulmonary disease of horses


subject: PUBCHEM.COMPOUND:9934746

object_name: COPD, severe early onset


subject: UNII:3E3D8T1GIX

subject_name: Ensifentrine


subject: UNII:3E3D8T1GIX


subject: CHEBI:8884

subject_name: Rocuronium

object_name: cardiac arrest


subject: CHEBI:8884

object_name: Cardiac Arrest, CTCAE


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: adult lymphoma


subject: UNII:28X28X9OKV

object_name: lymphoma


subject: UNII:28X28X9OKV

object_name: pediatric lymphoma


subject: UNII:28X28X9OKV

object_name: Childhood Solid Neoplasm


subject: UNII:28X28X9OKV

object_name: Solid Neoplasm


subject: UNII:28X28X9OKV

object_name: central nervous system cancer


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: CHEBI:3125

subject_name: Bisacodyl

object_name: Chronic constipation


subject: CHEBI:135552

subject_name: Prucalopride


subject: MESH:D011819

subject_name: Rabies Vaccines

object_name: Immunization reaction


subject: MESH:D011819

object_name: disease transmission


subject: MESH:D011819

object_name: Zoonoses


subject: CHEMBL.COMPOUND:CHEMBL2107909

subject_name: RABIES VACCINE


subject: CHEMBL.COMPOUND:CHEMBL2107909


subject: CHEMBL.COMPOUND:CHEMBL2107909


subject: UMLS:C2348671

subject_name: Fentanyl Sublingual Spray

object_name: cancer


subject: UMLS:C2348671

object_name: neoplasm


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: Unable to perform sex


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: CHEBI:183660

subject_name: Acetildenafil


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: CHEBI:9139

subject_name: Sildenafil


subject: UMLS:C4508793

object_name: Inflammatory abnormality of the eye


subject: CHEBI:240107

subject_name: Bromfenac


subject: CHEBI:10127

subject_name: Zonisamide

object_name: Kinetic tremor


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: malignant soft tissue neoplasm


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Locally Recurrent Head and Neck Squamous Cell Carcinoma


subject: CHEBI:31355

object_name: Locally Recurrent Oral Cavity Squamous Cell Carcinoma


subject: CHEBI:31355

object_name: Locally Recurrent Laryngeal Squamous Cell Carcinoma


subject: CHEBI:31355

object_name: Locally Recurrent Oropharyngeal Squamous Cell Carcinoma


subject: CHEBI:31355

object_name: Locally Recurrent Hypopharyngeal Squamous Cell Carcinoma


subject: CHEBI:31355

object_name: Stage II Oropharyngeal (p16-Negative) Carcinoma AJCC v8


subject: CHEBI:31355

object_name: Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8


subject: CHEBI:31355

object_name: Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8


subject: CHEBI:31355

object_name: Stage II Laryngeal Cancer AJCC v8


subject: CHEBI:31355

object_name: Stage III Laryngeal Cancer AJCC v8


subject: CHEBI:31355

object_name: Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


subject: CHEBI:31355

object_name: Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


subject: CHEBI:31355

object_name: Stage IVB Laryngeal Cancer AJCC v8


subject: CHEBI:31355

object_name: Stage IVA Laryngeal Cancer AJCC v8


subject: CHEBI:31355

object_name: Stage II Lip and Oral Cavity Cancer AJCC v8


subject: CHEBI:31355

object_name: Stage III Lip and Oral Cavity Cancer AJCC v8


subject: CHEBI:31355

object_name: Stage IVA Lip and Oral Cavity Cancer AJCC v8


subject: UNII:6QVL057INT

subject_name: Cemiplimab

object_name: Locally Recurrent Head and Neck Squamous Cell Carcinoma


subject: UNII:6QVL057INT


subject: UNII:6QVL057INT


subject: UNII:6QVL057INT


subject: UNII:6QVL057INT


subject: UNII:6QVL057INT


subject: UNII:6QVL057INT


subject: UNII:6QVL057INT


subject: UNII:6QVL057INT


subject: UNII:6QVL057INT


subject: UNII:6QVL057INT


subject: UNII:6QVL057INT


subject: UNII:6QVL057INT


subject: UNII:6QVL057INT


subject: UNII:6QVL057INT


subject: UNII:6QVL057INT


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863

object_name: Locally Recurrent Oral Cavity Squamous Cell Carcinoma


subject: CHEBI:45863

object_name: Locally Recurrent Laryngeal Squamous Cell Carcinoma


subject: CHEBI:45863

object_name: Locally Recurrent Oropharyngeal Squamous Cell Carcinoma


subject: CHEBI:45863

object_name: Locally Recurrent Hypopharyngeal Squamous Cell Carcinoma


subject: CHEBI:45863

object_name: Stage II Oropharyngeal (p16-Negative) Carcinoma AJCC v8


subject: CHEBI:45863

object_name: Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8


subject: CHEBI:45863

object_name: Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8


subject: CHEBI:45863

object_name: Stage II Laryngeal Cancer AJCC v8


subject: CHEBI:45863

object_name: Stage III Laryngeal Cancer AJCC v8


subject: CHEBI:45863

object_name: Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


subject: CHEBI:45863

object_name: Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


subject: CHEBI:45863

object_name: Stage IVB Laryngeal Cancer AJCC v8


subject: CHEBI:45863

object_name: Stage IVA Laryngeal Cancer AJCC v8


subject: CHEBI:45863

object_name: Stage II Lip and Oral Cavity Cancer AJCC v8


subject: CHEBI:45863

object_name: Stage III Lip and Oral Cavity Cancer AJCC v8


subject: CHEBI:45863

object_name: Stage IVA Lip and Oral Cavity Cancer AJCC v8


subject: CHEBI:188074

object_name: chronic kidney disease


subject: CHEBI:188074

object_name: Chronic Kidney Disease, CTCAE


subject: CHEBI:188074

object_name: Insulin resistance


subject: CHEBI:50122

subject_name: Rosiglitazone


subject: CHEBI:50122


subject: CHEBI:71954

subject_name: Buparlisib

object_name: myelofibrosis


subject: UMLS:C5964811


subject: UNII:3XVL385Q0M

subject_name: Filgotinib

object_name: psoriatic arthritis


subject: CHEBI:135207

subject_name: Clofedanol

object_name: colorectal cancer


subject: CHEBI:135207

object_name: colorectal carcinoma


subject: CHEBI:135207

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:95001

subject_name: Dalcetrapib

object_name: cardiovascular disorder


subject: PUBCHEM.COMPOUND:137441492

subject_name: ZASOCITINIB

object_name: ulcerative colitis


subject: PUBCHEM.COMPOUND:137441492

object_name: inflammatory bowel disease 1


subject: PUBCHEM.COMPOUND:137441492

object_name: Crohn disease


subject: DRUGBANK:DB19278

subject_name: Zasocitinib


subject: DRUGBANK:DB19278


subject: DRUGBANK:DB19278


subject: UNII:2W150K0UUC

subject_name: Odevixibat

object_name: progressive familial intrahepatic cholestasis type 1


subject: UNII:2W150K0UUC

object_name: progressive familial intrahepatic cholestasis type 2


subject: CHEBI:76842

object_name: pervasive developmental disorder


subject: CHEBI:76842

object_name: autism


subject: CHEBI:76842

object_name: autism spectrum disorder


subject: CHEBI:76842

object_name: Constipation


subject: CHEBI:76842

object_name: Constipation, CTCAE


subject: CHEBI:76842

object_name: digestive system disorder


subject: CHEBI:28001

subject_name: Vancomycin


subject: CHEBI:28001


subject: CHEBI:28001


subject: CHEBI:28001


subject: CHEBI:28001


subject: CHEBI:28001


subject: CHEBI:30742

subject_name: macrogol


subject: CHEBI:30742


subject: CHEBI:30742


subject: CHEBI:30742

object_name: diarrhea


subject: CHEBI:30742

object_name: rectal discharge diarrhea (physical finding)


subject: CHEBI:30742

object_name: Diarrhea, CTCAE


subject: CHEBI:30742


subject: UMLS:C5784955

subject_name: HMGB1 Inhibitor SB17170

object_name: Safety Issues


subject: CHEBI:18276

subject_name: Hydrogen

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:18276

object_name: obesity


subject: CHEBI:18276

object_name: Obesity, CTCAE


subject: CHEBI:63605

subject_name: Ixabepilone

object_name: testicular germ cell tumor 1


subject: CHEBI:63605

object_name: testicular germ cell tumor


subject: CHEBI:63605

object_name: childhood testicular germ cell tumor


subject: CHEBI:63605

object_name: extragonadal germ cell tumor


subject: CHEBI:63605

object_name: ovarian cancer


subject: CHEBI:63605

object_name: ovarian neoplasm


subject: CHEBI:63605

object_name: ovarian carcinoma


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Arthrosis, unspecified, ankle and foot


subject: UNII:T74V9O0Y2W

object_name: rhinitis


subject: CHEBI:15367

subject_name: Tretinoin

object_name: renal carcinoma


subject: CHEBI:15367

object_name: kidney neoplasm


subject: CHEBI:15367

object_name: kidney cancer


subject: GTOPDB:4985


subject: GTOPDB:4985


subject: GTOPDB:4985


subject: UMLS:C5139755

subject_name: Human interleukin-2


subject: UMLS:C5139755


subject: UMLS:C5139755


subject: PUBCHEM.COMPOUND:108123

subject_name: Entonox

object_name: Depressed mood


subject: PUBCHEM.COMPOUND:108123

object_name: Cancer patients and suicide and depression


subject: PUBCHEM.COMPOUND:108123

object_name: Depressed - symptom


subject: PUBCHEM.COMPOUND:108123

object_name: Depression, CTCAE


subject: CHEBI:141969

subject_name: Tipifarnib

object_name: colorectal cancer


subject: CHEBI:141969

object_name: colorectal carcinoma


subject: CHEBI:141969

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: PUBCHEM.COMPOUND:148193

subject_name: Tonapofylline


subject: PUBCHEM.COMPOUND:148193


subject: PUBCHEM.COMPOUND:148193


subject: UMLS:C0393031


subject: UMLS:C0393031


subject: UMLS:C0393031


subject: CHEBI:20392

subject_name: Hydroxyproline

object_name: Hyperoxaluria


subject: CHEBI:28397


subject: CHEBI:24741

subject_name: hydroxyproline


subject: CHEBI:25017

subject_name: leucine


subject: UMLS:C5418043

subject_name: ADC SHR-A1811


subject: UMLS:C5418043


subject: UMLS:C5418043


subject: CHEBI:4887

subject_name: Ethosuximide

object_name: irritable bowel syndrome


subject: CHEBI:50162

subject_name: motexafin gadolinium hydrate

object_name: lung cancer


subject: CHEBI:50162

object_name: lung carcinoma


subject: PUBCHEM.COMPOUND:9919910

subject_name: Xcytrin


subject: PUBCHEM.COMPOUND:9919910


subject: CHEBI:33375

subject_name: Gadolinium


subject: CHEBI:33375


subject: CHEMBL.COMPOUND:CHEMBL3544910

subject_name: MOTEXAFIN GADOLINIUM


subject: CHEMBL.COMPOUND:CHEMBL3544910


subject: UMLS:C1707141

object_name: ovarian cancer


subject: UMLS:C1707141

object_name: ovarian neoplasm


subject: UMLS:C1707141

object_name: ovarian carcinoma


subject: MESH:C079198

subject_name: S 1 (combination)

object_name: Small cell lung cancer recurrent


subject: UNII:GKF8S4C432

subject_name: Anlotinib


subject: PUBCHEM.COMPOUND:44151801

subject_name: Degarelix

object_name: prostate neoplasm


subject: UMLS:C0971731


subject: UNII:1B8447E7YI

subject_name: CLOMIPHENE CITRATE

object_name: female infertility


subject: CHEBI:75551


subject: UNII:T7K20Y2GWY

subject_name: Corifollitropin alfa


subject: RXCUI:1656336

subject_name: sacubitril / valsartan Oral Product

object_name: congenital heart disease


subject: DRUGBANK:DB17952

object_name: Multiple sclerosis relapse


subject: UMLS:C4757428

subject_name: Progesterone only product in oral dose form

object_name: Uses contraception (finding)


subject: CHEBI:27812

subject_name: Methylselenocysteine

object_name: complications of organ transplant stem cells umbilical cord


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin


subject: PUBCHEM.COMPOUND:2269

object_name: asthma


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: CHEBI:2955

subject_name: Azithromycin


subject: UNII:91X1KLU43E

subject_name: Golimumab

object_name: psoriatic arthritis


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: congenital heart block


subject: CHEBI:41879

object_name: neonatal lupus erythematosus


subject: CHEBI:41879

object_name: Myocardial injury


subject: PUBCHEM.COMPOUND:2269

object_name: pityriasis lichenoides


subject: UMLS:C0812732


subject: CHEBI:2955


subject: CHEMBL.COMPOUND:CHEMBL2107906

subject_name: PLAGUE VACCINE

object_name: plague


subject: DRUGBANK:DB15461

subject_name: Yersinia pestis 195/p antigen (formaldehyde inactivated)


subject: UMLS:C5397327

subject_name: Vaccine product containing only Yersinia pestis antigen (medicinal product)


subject: UMLS:C0032066

subject_name: Plague Vaccine


subject: CHEBI:52993

subject_name: Lormetazepam

object_name: Status epilepticus


subject: CHEBI:6539

subject_name: Lorazepam


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: Refractory Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:1805

object_name: Recurrent Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:1805

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: PUBCHEM.COMPOUND:1805

object_name: Recurrent Chronic Myelomonocytic Leukemia


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:75998

subject_name: Trametinib

object_name: Refractory acute myeloid leukemia


subject: CHEBI:75998


subject: CHEBI:75998


subject: CHEBI:75998


subject: CHEBI:75998

object_name: Recurrent Acute Myeloid Leukemia


subject: CHEBI:75998

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: CHEBI:75998


subject: CHEBI:133021

subject_name: Venetoclax


subject: CHEBI:133021


subject: CHEBI:9907

subject_name: ursodiol

object_name: Adenomatous colonic polyposis


subject: CHEBI:9130

subject_name: Sevoflurane

object_name: Postoperative cognitive dysfunction


subject: CHEBI:233197

subject_name: devimistat

object_name: pancreatic ductal adenocarcinoma


subject: UMLS:C2703200

subject_name: CPI 613


subject: PUBCHEM.COMPOUND:2307

subject_name: Andion

object_name: copd bronchitis


subject: PUBCHEM.COMPOUND:2307

object_name: pollution related respiratory disorder


subject: CHEBI:3001

subject_name: beclomethasone


subject: CHEBI:3001


subject: CHEBI:5147

subject_name: Formoterol


subject: CHEBI:5147


subject: CHEBI:408174

subject_name: Arformoterol


subject: CHEBI:408174


subject: CHEBI:91899


subject: CHEBI:91899


subject: CHEBI:3207

subject_name: Budesonide


subject: CHEBI:3207


subject: PUBCHEM.COMPOUND:21880659

subject_name: Vilanterol


subject: PUBCHEM.COMPOUND:21880659


subject: UNII:GE2T1418SV

subject_name: Umeclidinium


subject: UNII:GE2T1418SV


subject: CHEBI:33569

subject_name: noradrenaline

object_name: neoplasm


subject: CHEBI:33569

object_name: Tumor Mass


subject: CHEBI:33569

object_name: stroke disorder


subject: CHEBI:33569

object_name: cerebrovascular disorder


subject: CHEBI:33569

object_name: Stroke (heart beat)


subject: CHEBI:33569

object_name: Stroke, CTCAE


subject: CHEBI:18357

subject_name: Norepinephrine


subject: CHEBI:18357


subject: CHEBI:18357


subject: CHEBI:18357


subject: CHEBI:18357


subject: CHEBI:18357


subject: CHEBI:8093

subject_name: Phenylephrine


subject: CHEBI:8093


subject: CHEBI:8093


subject: CHEBI:8093


subject: CHEBI:8093


subject: CHEBI:8093


subject: CHEBI:8382

subject_name: Prednisone

object_name: autoimmune thrombocytopenic purpura


subject: CHEBI:9241

subject_name: Spironolactone

object_name: mild neurocognitive disorder


subject: CHEBI:9241

object_name: mild cognitive impairment


subject: CHEBI:9241

object_name: Alzheimer disease type 1


subject: CHEBI:9241

object_name: Alzheimer disease


subject: UNII:7CS0WNO31M

subject_name: QUININE HYDROCHLORIDE

object_name: Clinical malaria


subject: CHEBI:137041


subject: CHEBI:15854

subject_name: Quinine


subject: CHEBI:74820

subject_name: Ser-Pro


subject: CHEBI:80308

subject_name: substance P


subject: PR:000016275

subject_name: trefoil factor 2


subject: UniProtKB:Q03404

subject_name: TFF2_MOUSE Trefoil factor 2 (sprot)


subject: UNII:6FE8PG636R

subject_name: Saredutant succinate

object_name: Depressed mood


subject: CHEBI:233291

subject_name: Saredutant


subject: UNII:D99YVK4L0X

subject_name: Ramucirumab

object_name: Refractory Neoplasm


subject: UNII:D99YVK4L0X

object_name: Recurrent tumor


subject: UNII:D99YVK4L0X

object_name: Childhood Solid Neoplasm


subject: UNII:D99YVK4L0X

object_name: Malignant neoplasm of the central nervous system


subject: UMLS:C1721684

subject_name: lexatumumab


subject: UMLS:C1721684


subject: UMLS:C1721684


subject: UMLS:C1721684


subject: UMLS:C5418057

object_name: Childhood Breast Carcinoma


subject: UMLS:C5418057

object_name: breast carcinoma


subject: UMLS:C5418057

object_name: breast cancer


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: abnormal; pulmonary function, newborn


subject: CHEBI:38290

object_name: Passive Smoke Exposure


subject: CHEBI:176783

subject_name: vitamin C


subject: CHEBI:176783


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C3714687


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: UMLS:C2349136


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: CHEBI:22652


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UMLS:C4522080


subject: UMLS:C0772413

subject_name: Prenatal vitamin


subject: UMLS:C0772413


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: Lymphoma, Extranodal NK-T-Cell


subject: UMLS:C3896806


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: Military activity


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: UMLS:C3265062


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C2826136

subject_name: gamma secretase inhibitor PF-03084014

object_name: Kaposi Sarcoma


subject: UMLS:C2826136

object_name: Recurrent Kaposi Sarcoma


subject: UMLS:C2826136

object_name: HIV infection


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Refractory Indolent Adult Non-Hodgkin Lymphoma


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:231679

subject_name: ipilimumab

object_name: prostate carcinoma


subject: CHEBI:231679

object_name: prostate cancer


subject: UMLS:C4745029

subject_name: HLX 10

object_name: Adult Solid Neoplasm


subject: UMLS:C5666962

subject_name: Anti-LAG-3 Monoclonal Antibody HLX26


subject: CHEBI:36005

subject_name: docosahexaenoic acid

object_name: Pregnant


subject: CHEBI:28125

subject_name: Doconexent


subject: CHEBI:16016

subject_name: Glycerone


subject: CHEBI:28689

subject_name: Prasterone


subject: CHEBI:35627

subject_name: beta-lactam

object_name: bacteriemia


subject: CHEBI:35627

object_name: Bacteremia, CTCAE


subject: CHEBI:35627

object_name: streptococcal infection


subject: PUBCHEM.COMPOUND:16208013

subject_name: Tecemotide

object_name: lung cancer


subject: PUBCHEM.COMPOUND:16208013

object_name: lung neoplasm


subject: PUBCHEM.COMPOUND:16208013

object_name: lung carcinoma


subject: UNII:Q7Y026G2CX

subject_name: TECEMOTIDE


subject: UNII:Q7Y026G2CX


subject: UNII:Q7Y026G2CX


subject: UMLS:C1832016


subject: UMLS:C1832016


subject: UMLS:C1832016


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:71940

subject_name: Tadalafil

object_name: Erectile dysfunction due to diabetes mellitus


subject: CHEBI:229764

subject_name: Selinexor

object_name: Untreated Adult Acute Myeloid Leukemia


subject: GTOPDB:7988

subject_name: nimotuzumab


subject: GTOPDB:7988


subject: GTOPDB:7988


subject: UNII:6NS400BXKH


subject: UNII:6NS400BXKH


subject: UNII:6NS400BXKH


subject: UMLS:C1570308


subject: UMLS:C1570308


subject: UMLS:C1570308


subject: UMLS:C5435006

object_name: Alzheimer disease type 1


subject: UMLS:C5435006

object_name: Alzheimer disease


subject: UNII:B2I7YTE4ZA

subject_name: DUVAKITUG

object_name: Crohn disease


subject: UMLS:C5855311

subject_name: Duvakitug


subject: PUBCHEM.COMPOUND:57505028

subject_name: Suvorexant

object_name: Shift-Work Sleep Disorder


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: bile duct carcinoma


subject: CHEBI:5801

object_name: bile duct cancer


subject: CHEBI:5801

object_name: cholangiocarcinoma


subject: CHEBI:5801

object_name: biliary tract cancer


subject: CHEBI:5801

object_name: biliary tract neoplasm


subject: CHEBI:75998

subject_name: Trametinib


subject: CHEBI:75998


subject: CHEBI:75998


subject: CHEBI:75998


subject: CHEBI:75998


subject: UMLS:C4042170

object_name: hematopoietic and lymphoid system neoplasm


subject: UMLS:C4331923

subject_name: Oradoxel

object_name: Childhood Solid Neoplasm


subject: UMLS:C4331923

object_name: Adult Solid Neoplasm


subject: UMLS:C4331923

object_name: Solid Neoplasm


subject: CHEBI:50949

subject_name: serotonin uptake inhibitor

object_name: endogenous depression


subject: UMLS:C0360105

subject_name: Selective Serotonin Reuptake Inhibitors


subject: UMLS:C2911696

subject_name: Serotonin Reuptake Inhibitor [EPC]


subject: GTOPDB:12349

subject_name: zimberelimab

object_name: cervical cancer


subject: GTOPDB:12349

object_name: cervical carcinoma


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UMLS:C5204520


subject: UMLS:C5204520


subject: CHEBI:16118

subject_name: Berberine

object_name: Helicobacter pylori infection


subject: CHEBI:16118

object_name: chronic gastritis


subject: CHEBI:136048

subject_name: Vonoprazan


subject: CHEBI:73678

object_name: Fractured lower leg


subject: CHEBI:73678

object_name: Bone fracture


subject: CHEBI:73678

object_name: Fractures, Open


subject: CHEBI:73678

object_name: Arm Fracture


subject: CHEBI:73678

object_name: Wounds and injuries--Infections


subject: CHEBI:28864

subject_name: Tobramycin


subject: CHEBI:28864


subject: CHEBI:28864


subject: CHEBI:28864


subject: CHEBI:28864


subject: CHEBI:76842


subject: CHEBI:76842


subject: CHEBI:76842


subject: CHEBI:76842


subject: CHEBI:76842


subject: CHEBI:28001

subject_name: Vancomycin


subject: CHEBI:28001


subject: CHEBI:28001


subject: CHEBI:28001


subject: CHEBI:28001


subject: UNII:37L1JX37J5

subject_name: SABIZABULIN

object_name: triple-negative breast carcinoma


subject: MESH:C000710140

subject_name: sabizabulin


subject: PUBCHEM.COMPOUND:54675783

subject_name: minocycline

object_name: relapsing-remitting multiple sclerosis


subject: UMLS:C1328728

object_name: adult lymphoma


subject: UMLS:C1328728

object_name: lymphoma


subject: UMLS:C1328728

object_name: pediatric lymphoma


subject: UMLS:C5555006

object_name: head and neck squamous cell carcinoma


subject: UMLS:C3536908

subject_name: Omega-3 Fatty Acid [EPC]

object_name: post-traumatic stress disorder


subject: CHEBI:35674

subject_name: antihypertensive agent

object_name: preeclampsia


subject: UMLS:C0003364

subject_name: Antihypertensive Agents


subject: UNII:71M78END5S

subject_name: OMEGA-3 FATTY ACIDS


subject: CHEBI:25681

subject_name: Omega-3 fatty acids


subject: UMLS:C1510800

subject_name: Adenovirus Vector

object_name: colorectal cancer


subject: UMLS:C1510800

object_name: colorectal carcinoma


subject: UMLS:C1510800

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C1510800

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C1510800

object_name: Embolism, Tumor


subject: UMLS:C1510800

object_name: Neoplasm Metastasis


subject: CHEBI:6121

subject_name: Ketamine

object_name: OPIOID TOLERANCE


subject: UMLS:C0392938

subject_name: zoledronate

object_name: Osteopenia


subject: UMLS:C0392938

object_name: HIV infection


subject: CHEBI:46557

subject_name: Zoledronic acid


subject: CHEBI:46557


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: Transformed migraine


subject: UMLS:C0078058

subject_name: endothelial growth factor A, vascular

object_name: age-related macular degeneration


subject: UMLS:C1522575

subject_name: Recombinant Vascular Endothelial Growth Factor


subject: UMLS:C1256770

subject_name: Vascular Endothelial Growth Factors


subject: PR:000017284

subject_name: vascular endothelial growth factor A, long form


subject: CHEBI:77383

subject_name: 1,1-bis(phosphonic acid)

object_name: osteoporosis


subject: CHEBI:77383

object_name: Encounter due to family history of osteoporosis


subject: CHEBI:77383

object_name: Osteoporosis, CTCAE 5.0


subject: CHEBI:77383

object_name: Osteoporosis, CTCAE 3.0


subject: UMLS:C3541401

subject_name: Bisphosphonate drugs affecting bone structure and mineralization


subject: UMLS:C3541401


subject: UMLS:C3541401


subject: UMLS:C3541401


subject: MESH:D004164

subject_name: Diphosphonates


subject: MESH:D004164


subject: MESH:D004164


subject: MESH:D004164


subject: PUBCHEM.COMPOUND:6096882

subject_name: indocyanine green

object_name: unspecified adult solid tumor, protocol specific


subject: PUBCHEM.COMPOUND:6096882

object_name: lung cancer


subject: PUBCHEM.COMPOUND:6096882

object_name: lung neoplasm


subject: PUBCHEM.COMPOUND:6096882

object_name: lung carcinoma


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form


subject: UNII:C4V974V932


subject: UNII:C4V974V932


subject: UNII:C4V974V932


subject: CHEBI:6456

subject_name: Lidocaine


subject: CHEBI:6456


subject: CHEBI:6456


subject: CHEBI:6456


subject: MESH:C079198

subject_name: S 1 (combination)

object_name: Metastatic malignant neoplasm to peritoneum


subject: CHEBI:27732

subject_name: Caffeine

object_name: no feeling or sensation of skin


subject: CHEBI:27732

object_name: Sensory Loss


subject: CHEBI:51254

subject_name: AMOXICILLIN

object_name: Community-Acquired Pneumonia


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: UMLS:C2606671

object_name: Childhood Breast Carcinoma


subject: UMLS:C2606671

object_name: breast carcinoma


subject: UMLS:C2606671

object_name: breast cancer


subject: UMLS:C2984520


subject: UMLS:C2984520


subject: UMLS:C2984520


subject: CHEBI:6801

subject_name: Metformin

object_name: Well adult


subject: UMLS:C0920330

subject_name: Pancreatic enzyme

object_name: Child Malnutrition


subject: UMLS:C0920330

object_name: Sepsis


subject: UMLS:C0920330

object_name: Sepsis, CTCAE


subject: CHEBI:9907

subject_name: ursodiol


subject: CHEBI:9907


subject: CHEBI:9907


subject: UNII:XAV9KYN9WL

object_name: plasma cell myeloma


subject: GTOPDB:12690

subject_name: odronextamab

object_name: Richter syndrome


subject: GTOPDB:12690

object_name: Recurrent Transformed Chronic Lymphocytic Leukemia


subject: GTOPDB:12690

object_name: Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma


subject: GTOPDB:12690

object_name: Refractory Transformed Chronic Lymphocytic Leukemia


subject: UNII:8R5CM46UIO

subject_name: ODRONEXTAMAB


subject: UNII:8R5CM46UIO


subject: UNII:8R5CM46UIO


subject: UNII:8R5CM46UIO


subject: UMLS:C3896743

subject_name: Odronextamab


subject: UMLS:C3896743


subject: UMLS:C3896743


subject: UMLS:C3896743


subject: UNII:AG9MHG098Z

subject_name: Zanubrutinib


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: sickle cell disease


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: CHEBI:183660

subject_name: Acetildenafil


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: CHEBI:9139

subject_name: Sildenafil


subject: UNII:7XL5ISS668

subject_name: Adcetris

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: UMLS:C1832035


subject: CHEBI:17775

subject_name: Uric acid

object_name: Acute Ischemic Stroke


subject: CHEBI:17775

object_name: Ischemic stroke


subject: CHEBI:27226

subject_name: uric acid


subject: CHEBI:27226


subject: CHEBI:184555

subject_name: Xylan Sulfate

object_name: Iron Overload


subject: CHEBI:184555

object_name: iron poisoning


subject: CHEBI:184555

object_name: Iron Overload, CTCAE


subject: CHEBI:184555

object_name: thalassemia


subject: CHEBI:167574

subject_name: Semaglutide

object_name: hepatobiliary disorder


subject: UNII:KX7ZYR6OQW

subject_name: ENADENOTUCIREV

object_name: Epithelioma


subject: UNII:KX7ZYR6OQW

object_name: head and neck squamous cell carcinoma


subject: UNII:KX7ZYR6OQW

object_name: colorectal cancer


subject: UNII:KX7ZYR6OQW

object_name: colorectal carcinoma


subject: UNII:KX7ZYR6OQW

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:231614

subject_name: Nivolumab


subject: UMLS:C2346820


subject: CHEBI:7025

subject_name: Mupirocin

object_name: chronic rhinosinusitis


subject: PUBCHEM.COMPOUND:21014972

subject_name: Telavancin

object_name: Infection


subject: PUBCHEM.COMPOUND:21014972

object_name: infectious disease


subject: PUBCHEM.COMPOUND:21014972

object_name: Adverse Event Associated with Infection


subject: PUBCHEM.COMPOUND:21014972

object_name: bacteriemia


subject: PUBCHEM.COMPOUND:21014972

object_name: Bacteremia, CTCAE


subject: CHEBI:17061

subject_name: D-Glutamine

object_name: adult lymphoma


subject: CHEBI:17061

object_name: lymphoma


subject: CHEBI:17061

object_name: pediatric lymphoma


subject: CHEBI:28300

subject_name: glutamine


subject: CHEBI:28300


subject: CHEBI:28300


subject: CHEBI:18050

subject_name: L-Glutamine


subject: CHEBI:18050


subject: CHEBI:18050


subject: UMLS:C3714638

subject_name: Pyridoxine Drug Class


subject: UMLS:C3714638


subject: UMLS:C3714638


subject: CHEBI:27306

subject_name: vitamin B6


subject: CHEBI:27306


subject: CHEBI:27306


subject: PUBCHEM.COMPOUND:90467376

object_name: Mental deterioration


subject: PUBCHEM.COMPOUND:90467376

object_name: Cognitive impairment


subject: GTOPDB:7988

subject_name: nimotuzumab

object_name: pancreatic neoplasm


subject: GTOPDB:7988

object_name: exocrine pancreatic carcinoma


subject: GTOPDB:7988

object_name: malignant pancreatic neoplasm


subject: UNII:6NS400BXKH


subject: UNII:6NS400BXKH


subject: UNII:6NS400BXKH


subject: UMLS:C1570308


subject: UMLS:C1570308


subject: UMLS:C1570308


subject: UMLS:C3537161

subject_name: Dipeptidyl Peptidase 4 Inhibitor [EPC]

object_name: stroke disorder


subject: UMLS:C3537161

object_name: cerebral infarction


subject: UMLS:C3537161

object_name: cerebrovascular disorder


subject: UMLS:C3537161

object_name: brain infarction


subject: UMLS:C3537225

subject_name: Dipeptidyl Peptidase-4 Inhibitor


subject: UMLS:C3537225


subject: UMLS:C3537225


subject: UMLS:C3537225


subject: CHEBI:92223

subject_name: Abexinostat

object_name: diffuse large B-cell lymphoma


subject: UMLS:C1671982

object_name: heart failure


subject: UMLS:C1671982

object_name: congestive heart failure


subject: UMLS:C1671982

object_name: chronic obstructive pulmonary disease


subject: CHEBI:16646

subject_name: carbohydrate

object_name: irritable bowel syndrome


subject: CHEBI:16646


subject: MESH:D000073893

subject_name: Sugars


subject: MESH:D000073893


subject: UMLS:C3665462

subject_name: raw sugar


subject: UMLS:C3665462


subject: CHEBI:17992

subject_name: Sucrose


subject: CHEBI:17992


subject: CHEMBL.COMPOUND:CHEMBL2108181

subject_name: CHERRY JUICE

object_name: metabolic disturbance


subject: CHEMBL.COMPOUND:CHEMBL2108181

object_name: Dietary Exposure


subject: CHEBI:44915

subject_name: Propofol

object_name: Postoperative delirium


subject: CHEBI:44915

object_name: General anesthetic drug adverse reaction


subject: DRUGBANK:DB18396

object_name: Stage III Cutaneous Melanoma AJCC v6


subject: DRUGBANK:DB18396

object_name: Metastatic Cutaneous Melanoma


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: pancreatic acinar cell carcinoma


subject: CHEBI:229764

subject_name: Selinexor

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:229764

object_name: stage IV pancreatic cancer


subject: CHEBI:229764

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: CHEBI:229764


subject: CHEBI:229764

object_name: pancreatic ductal adenocarcinoma


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:46245

subject_name: Ubidecarenone

object_name: attention deficit hyperactivity disorder, inattentive type


subject: CHEBI:46245


subject: CHEBI:91397

subject_name: Ibrutinib

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: CHEBI:91397

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: UNII:Q6C9WHR03O

subject_name: tisagenlecleucel

object_name: diffuse large B-cell lymphoma


subject: UNII:Q6C9WHR03O


subject: UNII:Q6C9WHR03O


subject: CHEBI:600103

subject_name: daptomycin

object_name: Bacteremia caused by Staphylococcus aureus


subject: UMLS:C4724926

subject_name: Autologous Dendritic Cells Transduced with Wild-type p53 Adenovirus Vaccine

object_name: small cell lung carcinoma


subject: UMLS:C4724926

object_name: Small cell lung cancer recurrent


subject: UMLS:C4724926

object_name: lung cancer


subject: UMLS:C4724926

object_name: lung neoplasm


subject: UMLS:C4724926

object_name: lung carcinoma


subject: CHEBI:231679

subject_name: ipilimumab


subject: CHEBI:231679


subject: CHEBI:231679


subject: CHEBI:231679


subject: CHEBI:231614

subject_name: Nivolumab


subject: UMLS:C2346820


subject: PUBCHEM.COMPOUND:75163792

subject_name: Ibrexafungerp

object_name: allergic bronchopulmonary aspergillosis


subject: PUBCHEM.COMPOUND:75163792

object_name: Recurrent vulvovaginal candidiasis


subject: PUBCHEM.COMPOUND:75163792

object_name: Invasive pulmonary aspergillosis


subject: PUBCHEM.COMPOUND:75163792

object_name: Chronic pulmonary aspergillosis


subject: PUBCHEM.COMPOUND:75163792

object_name: Mucocutaneous candidiasis


subject: PUBCHEM.COMPOUND:75163792

object_name: chronic mucocutaneous candidiasis


subject: PUBCHEM.COMPOUND:75163792

object_name: disseminated candidiasis


subject: PUBCHEM.COMPOUND:75163792

object_name: candidiasis, invasive


subject: PUBCHEM.COMPOUND:75163792

object_name: coccidioidomycosis


subject: PUBCHEM.COMPOUND:75163792

object_name: histoplasmosis


subject: PUBCHEM.COMPOUND:75163792

object_name: blastomycosis


subject: CHEBI:84500

subject_name: varenicline

object_name: habits (history)


subject: CHEBI:31348

subject_name: Capecitabine

object_name: Distal Cholangiocarcinoma


subject: CHEBI:31348

object_name: Klatskin Tumor


subject: GTOPDB:12989

subject_name: toripalimab

object_name: Stage IV Gallbladder Cancer AJCC v8


subject: GTOPDB:12989

object_name: Stage IIB Gallbladder Cancer AJCC v8


subject: GTOPDB:12989

object_name: gallbladder cancer


subject: GTOPDB:12989

object_name: Stage IIA Gallbladder Cancer AJCC v8


subject: GTOPDB:12989

object_name: Stage III Gallbladder Cancer AJCC v8


subject: GTOPDB:12989

object_name: Stage 0 Gallbladder Cancer AJCC v8


subject: GTOPDB:12989

object_name: gallbladder carcinoma


subject: GTOPDB:12989


subject: GTOPDB:12989


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: UMLS:C4329337


subject: UMLS:C4329337


subject: UMLS:C4329337


subject: UMLS:C4329337


subject: UMLS:C4329337


subject: UMLS:C4329337


subject: UMLS:C4329337


subject: UMLS:C4329337


subject: MESH:C530986

subject_name: Glucerna

object_name: type 2 diabetes mellitus


subject: MESH:C530986

object_name: maturity-onset diabetes of the young type 1


subject: UNII:C3VX249T6L

subject_name: Ravulizumab

object_name: atypical hemolytic-uremic syndrome


subject: UMLS:C4086207


subject: UNII:SH41QYH8E5

subject_name: Propacetamol hydrochloride

object_name: post operative nausea and vomiting


subject: UMLS:C0771433


subject: PUBCHEM.COMPOUND:9971980

subject_name: Tramal


subject: CHEBI:32250

subject_name: tramadol hydrochloride


subject: CHEBI:75722

subject_name: Tramadol


subject: UMLS:C5854614

subject_name: BCR Signaling Pathway Inhibitor DZD8586

object_name: chronic lymphocytic leukemia/small lymphocytic lymphoma


subject: CHEBI:6456

subject_name: Lidocaine

object_name: shoulder impingement syndrome


subject: CHEBI:6456

object_name: Coracohumeral Impingement Syndrome


subject: UNII:C88817F47Y

object_name: triple-negative breast carcinoma


subject: UNII:C88817F47Y

object_name: Triple-Negative Breast Cancer Finding


subject: UNII:820NH671E6

subject_name: Prexasertib


subject: UNII:820NH671E6


subject: CHEBI:66964

subject_name: Dronabinol

object_name: post-traumatic stress disorder


subject: UMLS:C4289970

subject_name: Anti-PD1 Monoclonal Antibody

object_name: liver carcinoma


subject: CHEBI:145431

subject_name: Indisulam

object_name: colorectal cancer


subject: CHEBI:145431

object_name: colorectal carcinoma


subject: CHEBI:145431

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C0879271


subject: UMLS:C0879271


subject: UMLS:C0879271


subject: CHEBI:5959

subject_name: Irbesartan

object_name: chronic kidney disease


subject: CHEBI:5959

object_name: Chronic uremia


subject: GTOPDB:4985

object_name: metastatic colorectal cancer


subject: PR:000001379


subject: UMLS:C5139755

subject_name: Human interleukin-2


subject: CHEBI:6456

object_name: glioblastoma


subject: CHEBI:6456

object_name: Childhood Glioblastoma


subject: CHEBI:6456

object_name: adult glioblastoma


subject: UMLS:C3272772


subject: CHEBI:32184

subject_name: Tazarotene

object_name: Chronic small plaque psoriasis


subject: CHEBI:91899

object_name: microscopic colitis


subject: CHEBI:3207

subject_name: Budesonide


subject: MESH:C000627770

subject_name: folfirinox

object_name: Surgical procedure finding


subject: MESH:C000627770

object_name: Locally Advanced Pancreatic Adenocarcinoma


subject: CHEBI:91435

subject_name: Linifanib

object_name: non-small cell lung carcinoma


subject: UMLS:C1737951

subject_name: linifanib


subject: UMLS:C3859612

subject_name: Hyqvia

object_name: chronic inflammatory demyelinating polyradiculoneuropathy


subject: CHEBI:421707

subject_name: Abacavir

object_name: HIV-1 infection


subject: PR:000023218

subject_name: methionine import ATP-binding protein MetN


subject: CHEBI:92994

subject_name: ambroxol

object_name: pharyngitis


subject: CHEBI:92994

object_name: Pharyngitis, CTCAE


subject: CHEBI:135590

subject_name: Ambroxol


subject: CHEBI:135590


subject: CHEBI:5100

subject_name: Flucytosine

object_name: Cryptococcal meningitis


subject: CHEBI:95165

object_name: thrombocytopenia


subject: CHEBI:95165

object_name: hematologic disorder


subject: CHEBI:50131

subject_name: Decitabine


subject: CHEBI:50131


subject: UMLS:C0392939

subject_name: recombinant human thrombopoietin


subject: CHEBI:168243

subject_name: Valproic acid glucuronide

object_name: cancer


subject: CHEBI:168243

object_name: neoplasm


subject: CHEBI:39867

subject_name: Valproic acid


subject: CHEBI:39867


subject: CHEBI:230518

subject_name: Defencath

object_name: Infection of hemodialysis catheter


subject: CHEBI:230518

object_name: dialysis catheter; thrombosis


subject: UMLS:C5874382

subject_name: heparin / taurolidine


subject: UMLS:C5874382


subject: CHEBI:8427

subject_name: Probucol

object_name: Alzheimer disease


subject: CHEBI:8427

object_name: Age-related cognitive decline


subject: CHEBI:176795

subject_name: pyridinium chlorochromate

object_name: Intracranial hemorrhage


subject: UNII:03ZI7ZZW5Q


subject: GTOPDB:9758

subject_name: camrelizumab

object_name: lung neoplasm


subject: UNII:73096E137E


subject: UMLS:C5669600

subject_name: Ivonescimab

object_name: Small cell lung cancer extensive stage


subject: UNII:63WI9S8P1M

subject_name: Tinlarebant

object_name: Dry age-related macular degeneration


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: Metastatic malignant neoplasm to bone


subject: CHEBI:72317

object_name: castration-resistant prostate carcinoma


subject: CHEBI:72317

object_name: Prostate cancer recurrent


subject: CHEBI:72317

object_name: Stage IV Prostate Cancer AJCC v6


subject: CHEBI:72317

object_name: Carcinoma of the prostate stage IV


subject: CHEBI:72317

object_name: Stage IV Prostate Cancer AJCC v7


subject: CHEBI:72317

object_name: Stage IV Prostate Cancer AJCC v8


subject: DRUGBANK:DB15803

subject_name: Dendritic cells vaccine

object_name: malignant glioma


subject: CHEBI:499361

subject_name: Aprepitant

object_name: glioblastoma


subject: CHEBI:499361

object_name: Childhood Glioblastoma


subject: CHEBI:499361

object_name: adult glioblastoma


subject: CHEBI:2922

subject_name: Auranofin


subject: CHEBI:2922


subject: CHEBI:2922


subject: CHEBI:3380

subject_name: Captopril


subject: CHEBI:3380


subject: CHEBI:3380


subject: UMLS:C0006938

subject_name: captopril


subject: UMLS:C0006938


subject: UMLS:C0006938


subject: CHEBI:41423

subject_name: Celecoxib


subject: CHEBI:41423


subject: CHEBI:41423


subject: CHEBI:94366

subject_name: itraconazole


subject: CHEBI:94366


subject: CHEBI:94366


subject: PUBCHEM.COMPOUND:54675783

subject_name: minocycline


subject: PUBCHEM.COMPOUND:54675783


subject: PUBCHEM.COMPOUND:54675783


subject: CHEBI:45409

subject_name: Ritonavir


subject: CHEBI:45409


subject: CHEBI:45409


subject: CHEBI:9123

subject_name: Sertraline


subject: CHEBI:9123


subject: CHEBI:9123


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: Tranexamic acid adverse reaction


subject: CHEBI:31236

subject_name: Aripiprazole

object_name: social phobia


subject: CHEBI:93775

subject_name: Amethopterin

object_name: gout


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:95060

subject_name: Dinaciclib

object_name: acute lymphoblastic leukemia


subject: CHEBI:95060

object_name: acute myeloid leukemia


subject: UMLS:C2711996


subject: UMLS:C2711996


subject: CHEBI:681569

subject_name: Clofarabine

object_name: plasma cell myeloma


subject: CHEBI:9570

subject_name: Thiotepa


subject: UMLS:C0308312

subject_name: amino acid solution

object_name: acute kidney failure


subject: UMLS:C0308312

object_name: liver failure


subject: UMLS:C0308312

object_name: Hepatic Failure, CTCAE


subject: PUBCHEM.COMPOUND:91820602

subject_name: Hyaluronidase

object_name: AL amyloidosis


subject: UMLS:C5383290

subject_name: hyaluronidase-fihj


subject: UNII:54534MX6Z9

subject_name: Teclistamab


subject: UMLS:C4527013


subject: CHEBI:601027

subject_name: Aliskiren

object_name: type 2 diabetes mellitus


subject: CHEBI:601027

object_name: Insulin resistance


subject: CHEBI:601027

object_name: coronary microvascular disorder


subject: CHEBI:601027

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:601027

object_name: metabolic syndrome X


subject: CHEBI:29007

subject_name: Ceftriaxone

object_name: schizophrenia


subject: CHEBI:29007

object_name: schizoaffective disorder


subject: CHEBI:29007

object_name: schizophrenia 18


subject: CHEBI:29007

object_name: psychosis


subject: CHEBI:29007

object_name: Nonorganic psychosis


subject: CHEBI:29007

object_name: Psychosis, CTCAE


subject: UNII:5085ZFP6SJ

subject_name: TOZINAMERAN

object_name: Maternal vaccine exposure


subject: UNII:5085ZFP6SJ

object_name: Respiratory infections in children


subject: UNII:JSV288Q5CV

subject_name: Famtozinameran


subject: UNII:JSV288Q5CV


subject: CHEBI:86465

subject_name: Kalinite

object_name: HIV infection


subject: UNII:I7T908772F

subject_name: alum


subject: CHEBI:86463

subject_name: Potassium alum


subject: UNII:71M78END5S

subject_name: OMEGA-3 FATTY ACIDS

object_name: cancer


subject: UNII:71M78END5S

object_name: neoplasm


subject: UNII:71M78END5S

object_name: cardiovascular disorder


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL


subject: CHEMBL.COMPOUND:CHEMBL3833369


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina


subject: PUBCHEM.COMPOUND:2735


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: PUBCHEM.COMPOUND:10883523


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: CHEBI:91508

subject_name: Racecadotril

object_name: acute diarrhea


subject: CHEBI:91508

object_name: Acute gastroenteritis


subject: CHEMBL.COMPOUND:CHEMBL2109092

subject_name: EPOETIN BETA

object_name: type 2 diabetes mellitus


subject: CHEMBL.COMPOUND:CHEMBL2109092

object_name: Diabetes


subject: CHEMBL.COMPOUND:CHEMBL2109092

object_name: diabetes mellitus


subject: UMLS:C3537225

subject_name: Dipeptidyl Peptidase-4 Inhibitor


subject: CHEBI:26831

subject_name: N,N''-sulfonyldiurea


subject: MESH:D013453

subject_name: Sulfonylurea Compounds


subject: CHEBI:8378

subject_name: Prednisolone

object_name: rheumatoid arthritis


subject: CHEBI:7465

subject_name: Naltrexone

object_name: lobular breast carcinoma in situ


subject: CHEBI:7465

object_name: lobular neoplasia


subject: CHEBI:7465

object_name: ductal breast carcinoma in situ


subject: CHEBI:7465

object_name: breast lobular carcinoma


subject: CHEBI:7465

object_name: invasive lobular breast carcinoma


subject: PUBCHEM.COMPOUND:10016910

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C1831757


subject: PUBCHEM.COMPOUND:5460037

subject_name: isomaltotriose

object_name: acute pancreatitis


subject: PUBCHEM.COMPOUND:5460037

object_name: Acute pancreatic fluid collection


subject: PUBCHEM.COMPOUND:4125253

subject_name: Dextran


subject: PUBCHEM.COMPOUND:4125253


subject: CHEBI:52071

subject_name: dextran


subject: CHEBI:52071


subject: CHEBI:34674

subject_name: dextran sulfate


subject: CHEBI:34674


subject: CHEBI:9584

subject_name: desiccated thyroid extract

object_name: hypothyroidism


subject: CHEBI:9584

object_name: Hypothyroidism, CTCAE


subject: PUBCHEM.COMPOUND:23670461

subject_name: Thyradin


subject: PUBCHEM.COMPOUND:23670461


subject: UMLS:C1881373

subject_name: Synthetic Levothyroxine


subject: UMLS:C1881373


subject: CHEBI:18332

subject_name: Levothyroxine


subject: CHEBI:18332


subject: CHEBI:6128

subject_name: Ketoprofen

object_name: Musculoskeletal Pain


subject: CHEBI:27732

subject_name: Caffeine


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: cardiovascular surgery result: left ventricular function


subject: UMLS:C1527137

object_name: Persistent pulmonary hypertension


subject: CHEBI:16796

subject_name: Melatonin


subject: CHEBI:16796


subject: CHEBI:60791

subject_name: Xylocard

object_name: Parkinson disease


subject: CHEBI:6456

subject_name: Lidocaine


subject: CHEBI:68579

subject_name: Rivaroxaban

object_name: acute coronary syndrome


subject: UNII:MQ908Y1ZB2

object_name: chronic pain (diagnosis)